PGIM Jennison Blend Fund Q1 2025 Commentary
Source: SeekingAlpha
2025-05-09 11:30:00 ET
Summary
- The PGIM Jennison Blend Fund underperformed the -4.7% return of the Russell 3000 Index during the quarter.
- Stock selection within the Information Technology, Financials, Health Care, and Consumer Staples sectors detracted the most.
- From a small-cap perspective, the team continues to identify attractively valued companies that have strong fundamentals, along with stable and high-quality balance sheets and profit margins.
Performance Recap
Read the full article on Seeking Alpha
For further details see:
PGIM Jennison Blend Fund Q1 2025 Commentary
AbbVie Inc.
NASDAQ: ABBV
ABBV Trading
2.61% G/L:
$229.18 Last:
2,858,492 Volume:
$227.37 Open:
ABBV Latest News
June 02, 2026 02:50:00 pm
Johnson & Johnson Hopes to Dethrone AbbVie's Biggest Growth Driver. Here's Why Investors Shouldn't Panic
June 02, 2026 10:05:00 am
The S&P 500 Is Expensive, but These 3 Dividend Stocks Still Look Like Bargains
June 02, 2026 08:00:00 am
AbbVie to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
ABBV Stock Data
$396,361,630,803
1,749,710,786
N/A
2503
N/A
Pharmaceuticals
Healthcare
US
North Chicago
